share_log

Earnings Beat: Camden National Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Earnings Beat: Camden National Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

收益超過預期:卡姆登國家公司剛剛超過了分析師的預期,分析師一直在更新他們的模型
Simply Wall St ·  05/03 07:42

It's been a good week for Camden National Corporation (NASDAQ:CAC) shareholders, because the company has just released its latest quarterly results, and the shares gained 4.7% to US$32.13. It looks like a credible result overall - although revenues of US$42m were what the analysts expected, Camden National surprised by delivering a (statutory) profit of US$0.91 per share, an impressive 29% above what was forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

對於卡姆登國家公司(納斯達克股票代碼:CAC)的股東來說,這是美好的一週,因爲該公司剛剛發佈了最新的季度業績,股價上漲了4.7%,至32.13美元。總體而言,這似乎是一個可信的業績——儘管分析師預期的收入爲4200萬美元,但Camden National驚訝地實現了每股0.91美元的(法定)利潤,比預期高出29%。對於投資者來說,盈利是一個重要時刻,因爲他們可以追蹤公司的業績,查看分析師對明年的預測,看看對公司的情緒是否發生了變化。考慮到這一點,我們收集了最新的法定預測,以了解分析師對明年的預期。

earnings-and-revenue-growth
NasdaqGS:CAC Earnings and Revenue Growth May 3rd 2024
NASDAQGS: CAC 收益和收入增長 2024 年 5 月 3 日

After the latest results, the four analysts covering Camden National are now predicting revenues of US$169.8m in 2024. If met, this would reflect a satisfactory 4.4% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to increase 3.4% to US$3.10. Before this earnings report, the analysts had been forecasting revenues of US$171.9m and earnings per share (EPS) of US$3.03 in 2024. So the consensus seems to have become somewhat more optimistic on Camden National's earnings potential following these results.

根據最新業績,負責卡姆登國家銀行的四位分析師現在預測2024年的收入爲1.698億美元。如果得到滿足,這將反映出與過去12個月相比收入的令人滿意地增長了4.4%。預計每股法定收益將增長3.4%,至3.10美元。在本業績發佈之前,分析師一直預測2024年的收入爲1.719億美元,每股收益(EPS)爲3.03美元。因此,在這些業績公佈後,人們對Camden National的盈利潛力的共識似乎變得更加樂觀了。

There's been no major changes to the consensus price target of US$35.33, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Camden National, with the most bullish analyst valuing it at US$37.00 and the most bearish at US$34.00 per share. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

35.33美元的共識目標股價沒有重大變化,這表明每股收益前景的改善不足以對股票估值產生長期的積極影響。但是,這並不是我們可以從這些數據中得出的唯一結論,因爲一些投資者在評估分析師目標股價時也喜歡考慮估計值的差異。對卡姆登國民的看法有所不同,最看漲的分析師將其估值爲37.00美元,最看跌的爲每股34.00美元。由於估值範圍如此狹窄,分析師顯然對他們認爲的業務價值有相似的看法。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analysts are definitely expecting Camden National's growth to accelerate, with the forecast 5.9% annualised growth to the end of 2024 ranking favourably alongside historical growth of 1.2% per annum over the past five years. Other similar companies in the industry (with analyst coverage) are also forecast to grow their revenue at 6.0% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Camden National is expected to grow at about the same rate as the wider industry.

從現在的大局來看,我們可以理解這些預測的方法之一是看看它們如何與過去的業績和行業增長預期相比較。分析師們肯定預計,卡姆登國民的增長將加速,預計到2024年底的年化增長率爲5.9%,而過去五年的歷史年增長率爲1.2%。預計該行業其他類似公司(有分析師報道)的收入也將以每年6.0%的速度增長。考慮到收入增長的預測,很明顯,Camden National的增長速度預計將與整個行業大致相同。

The Bottom Line

底線

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Camden National following these results. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at US$35.33, with the latest estimates not enough to have an impact on their price targets.

這裏最重要的是,分析師上調了每股收益的預期,這表明在這些業績公佈後,對卡姆登國民的樂觀情緒明顯增強。他們還重申了收入預期,預計該公司的增長速度將與整個行業大致相同。共識目標股價穩定在35.33美元,最新估計不足以對其目標價格產生影響。

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Camden National going out to 2025, and you can see them free on our platform here..

根據這種思路,我們認爲該業務的長期前景比明年的收益重要得多。在Simply Wall St,我們有分析師對Camden National到2025年的全方位估計,你可以在我們的平台上免費看到這些估計。

You can also see whether Camden National is carrying too much debt, and whether its balance sheet is healthy, for free on our platform here.

您還可以在我們的平台上免費查看Camden National的債務是否過多,以及其資產負債表是否健康。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論